Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TraceTrust is a private U.S. cannabis and hemp compliance and certification company focused on product safety, dose accuracy, manufacturing quality, and consumer trust for ingestible products. The company provides strategic roadmaps, operational consulting, founder support, due diligence, HACCP training, and GMP-oriented certification services for cannabis and hemp manufacturers. TraceTrust is best known for creating A True Dose, an independent certification program intended to validate dose accuracy, ingredient transparency, instructions for use, and label claims, as well as hGMP-related quality programs. Its business is service- and standards-driven rather than drug-development driven, with an emphasis on helping regulated consumer health and wellness products exceed baseline compliance requirements. The company appears to operate commercially in the United States as an active private business led by co-founders Merril Gilbert and Rhiannon Woo.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TraceTrust.